The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...

Since District Judge Brian Murphy’s March 16th stay left the Advisory Committee on Immunization Practices (ACIP) without a ...

Pregnant women are at heightened risk for severe outcomes from infectious diseases like COVID-19, yet were not included in initial vaccine trials, which may contribute to low booster uptake (15% or ...

Walensky is a professor at Harvard Medical School and served as the 19th director of the Centers for Disease Control and Prevention. Once clinical trials showed that Covid-19 vaccines were safe and ...

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

The 2024-2025 COVID-19 vaccine was associated with reduced risk for COVID-19-related major adverse cardiovascular events ...